Negara: Inggris
Bahasa: Inggris
Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)
Prednisolone
Alliance Healthcare (Distribution) Ltd
H02AB06
Prednisolone
1mg
Gastro-resistant tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200
Prednisolone 1mg PIL UK 004 PATIENT INFORMATION LEAFLET PREDNISOLONE 1MG GASTRO-RESISTANT TABLETS PREDNISOLONE LEAFLET – HEADLINES • PREDNISOLONE IS A STEROID MEDICINE, prescribed for many different conditions, including serious illnesses. • YOU NEED TO TAKE IT REGULARLY to get the maximum benefit. • DON’T STOP TAKING THIS MEDICINE without talking to your doctor – you may need to reduce the dose gradually. • PREDNISOLONE CAN CAUSE SIDE EFFECTS IN SOME PEOPLE (read Section 4 Possible Side Effects below). Some problems such as mood changes (feeling depressed, or ‘high’), or stomach problems can happen straight away. If you feel unwell in any way, keep taking your tablets, BUT SEE YOUR DOCTOR STRAIGHT AWAY. • SOME SIDE EFFECTS ONLY HAPPEN AFTER WEEKS OR MONTHS. These include weakness of arms and legs or developing a rounder face (read Section 4 Possible Side Effects for more information) • IF YOU TAKE IT FOR MORE THAN 3 WEEKS, YOU WILL GET A BLUE ‘STEROID CARD’: always keep it with you and show it to any doctor or nurse treating you. • KEEP AWAY FROM PEOPLE WHO HAVE CHICKENPOX OR SHINGLES, if you have never had them. They could affect you severely. If you do come into contact with chickenpox or shingles, SEE YOUR DOCTOR STRAIGHT AWAY. NOW READ THE REST OF THIS LEAFLET. It includes other important information on the safe and effective use of this medicine that might be especially important for you. THIS LEAFLET WAS LAST REVISED: AUGUST 2017. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. Predni Baca dokumen lengkapnya
OBJECT 1 PREDNISOLONE 1MG GASTRO-RESISTANT TABLETS Summary of Product Characteristics Updated 08-Sep-2017 | Alliance Pharmaceuticals • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Deltacortril 1 mg Gastro-resistant Tablets Prednisolone 1 mg Gastro-resistant Tablets 2. Qualitative and quantitative composition Each tablet contains 1mg of Prednisolone. Excipients: also includes lactose (33.80mg). For a full list of excipients, see Section 6.1. 3. Pharmaceutical form Gastro-resistant Tablets Yellow, round biconvex gastro-resistant tablets of approximately 6.8mm in diameter. 4. Clinical particulars 4.1 Therapeutic indications _ALLERGY AND ANAPHYLAXIS_: bronchial asthma, drug hypersensitivity reactions, serum sickness, angioneurotic oedema, anaphylaxis. _ARTERITIS/COLLAGENOSIS_: giant cell arteritis/polymyalgia rheumatica, mixed connective tissue disease, polyarteritis nodosa, polymyositis. _BLOOD DISORDERS_: haemolytic anaemia (auto-immune), leukaemia (acute and chronic lymp Baca dokumen lengkapnya